With the 2016 regulations moving ever closer for the e-cig market and early announcements that e-liquid and vaping products will be regulated as medicines by MHRA and FDA, it is fair to say that both tobacco and e-cig manufacturers are extremely concerned.
The new regulations could see all rights for current e-liquid producers removed and only companies that hold a medical licence able to produce and distribute e-liquid. The result of this could cause leading e-cig brands like V2, VIP, Socialites and Blu to simply disappear, leaving the door open to the existing pharmaceutical corporations to take control of vaporizing E-meds or V-meds (vaporizing medicines)
Regulated medical E-liquid
A medical licence is not an easy thing to obtain and the pharmaceutical industry has one of the toughest regulatory bodies to enforce this. There are already well-established companies that are in favour with current governments and they are among the biggest corporations on the planet, GlaxoSmithKlien and Pfizer to name a couple and would be likely candidates to produce regulated medical E-liquid.
It is very likely that these long-standing well-established companies will take over the production and distribution of e-liquid, and sales by those outside the close-knit industry will be made illegal. Considering the pharmaceutical industries’ overall power it is very unlikely that all existing e-cig brands and tobacco companies will be granted a medial licence to produce e-liquid.
Who will control E-medicine?
The control and management of e-medicine will be a lengthy battle and is likely to be heavily debated and disputed in the courts. Appeal processes and law clarification will take a very long time; during this period e-cig brands will most likely continue business as usual. Inevitably though the pharmaceutical companies will come out on top in the battle of who will control E-medicine.
The plan is to bring out e-liquid with a medicinal applications such as vapable cold and flu syrup, painkillers and aspirin. With the development of these innovative e-meds and e-liquid, and the move towards stringent regulation under medicinal guidelines, it is plain to see where this fledgling industry is heading. Private companies like Alsa Refinish LLC are hoping to tap into the next highly lucrative market by patenting a specific e-smoking device for use as a medical administration device.
A little research shows that Alsa refinish LLC are a paint manufacturing company, evidently hoping to branch out and place their bets on the potential of a booming e-med/v-med industry. It is ridiculous to think that a company of this size, and with their expertise in stark contrast to the medical industry, could ever compete with the likes of the pharmaceutical giants, especially as they currently produce no regulated medicines.
Aiming to patent such a broad field, inclusive of so many possible variations of e-liquid ingredients, flavours, ergonomic design and application, it seems ludicrous to think that a paint manufacturing business believes they could control the manufacturing and distribution of the abundance of products that will be brought to market. I highly doubt they will successfully obtain rights to all manner of e-liquid formulas and device designs, but I guess it’s an ambitious goal and I don’t blame them for trying!